Your browser doesn't support javascript.
loading
Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations.
Petros, Brittany A; Turcinovic, Jacquelyn; Welch, Nicole L; White, Laura F; Kolaczyk, Eric D; Bauer, Matthew R; Cleary, Michael; Dobbins, Sabrina T; Doucette-Stamm, Lynn; Gore, Mitch; Nair, Parvathy; Nguyen, Tien G; Rose, Scott; Taylor, Bradford P; Tsang, Daniel; Wendlandt, Erik; Hope, Michele; Platt, Judy T; Jacobson, Karen R; Bouton, Tara; Yune, Seyho; Auclair, Jared R; Landaverde, Lena; Klapperich, Catherine M; Hamer, Davidson H; Hanage, William P; MacInnis, Bronwyn L; Sabeti, Pardis C; Connor, John H; Springer, Michael.
Afiliação
  • Petros BA; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
  • Turcinovic J; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
  • Welch NL; Division of Health Sciences and Technology, Harvard Medical School and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • White LF; Harvard/Massachusetts Institute of Technology, MD-PhD Program, Boston, Massachusetts, USA.
  • Kolaczyk ED; National Emerging Infectious Diseases Laboratories, Boston, Massachusetts, USA.
  • Bauer MR; Bioinformatics Program, Boston University, Boston, Massachusetts, USA.
  • Cleary M; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
  • Dobbins ST; Harvard Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, Massachusetts, USA.
  • Doucette-Stamm L; Department of Biostatistics, School of Public Health, Boston University, Boston, Massachusetts, USA.
  • Gore M; Department of Mathematics & Statistics, Boston University, Boston, Massachusetts, USA.
  • Nair P; Rafik B. Hariri Institute for Computing and Computational Science and Engineering, Boston University, Boston, Massachusetts, USA.
  • Nguyen TG; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
  • Rose S; Harvard Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, Massachusetts, USA.
  • Taylor BP; Harvard University Clinical Laboratory, Harvard University, Cambridge, Massachusetts, USA.
  • Tsang D; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
  • Wendlandt E; Boston University Clinical Testing Laboratory, Boston University Boston, Massachusetts, USA.
  • Hope M; Integrated DNA Technologies, Inc, Coralville, Iowa, USA.
  • Platt JT; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
  • Jacobson KR; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
  • Bouton T; Integrated DNA Technologies, Inc, Coralville, Iowa, USA.
  • Yune S; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Auclair JR; Integrated DNA Technologies, Inc, Coralville, Iowa, USA.
  • Landaverde L; Integrated DNA Technologies, Inc, Coralville, Iowa, USA.
  • Klapperich CM; Harvard University Clinical Laboratory, Harvard University, Cambridge, Massachusetts, USA.
  • Hamer DH; Boston University Student Health Services, Boston, Massachusetts, USA.
  • Hanage WP; Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
  • MacInnis BL; Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
  • Sabeti PC; Student Affairs, Northeastern University, Boston, Massachusetts, USA.
  • Connor JH; Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.
  • Springer M; Life Sciences Testing Center, Northeastern University, Burlington, Massachusetts, USA.
Clin Infect Dis ; 76(3): e400-e408, 2023 02 08.
Article em En | MEDLINE | ID: mdl-35616119
ABSTRACT

BACKGROUND:

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly transmissible in vaccinated and unvaccinated populations. The dynamics that govern its establishment and propensity toward fixation (reaching 100% frequency in the SARS-CoV-2 population) in communities remain unknown. Here, we describe the dynamics of Omicron at 3 institutions of higher education (IHEs) in the greater Boston area.

METHODS:

We use diagnostic and variant-specifying molecular assays and epidemiological analytical approaches to describe the rapid dominance of Omicron following its introduction into 3 IHEs with asymptomatic surveillance programs.

RESULTS:

We show that the establishment of Omicron at IHEs precedes that of the state and region and that the time to fixation is shorter at IHEs (9.5-12.5 days) than in the state (14.8 days) or region. We show that the trajectory of Omicron fixation among university employees resembles that of students, with a 2- to 3-day delay. Finally, we compare cycle threshold values in Omicron vs Delta variant cases on college campuses and identify lower viral loads among college affiliates who harbor Omicron infections.

CONCLUSIONS:

We document the rapid takeover of the Omicron variant at IHEs, reaching near-fixation within the span of 9.5-12.5 days despite lower viral loads, on average, than the previously dominant Delta variant. These findings highlight the transmissibility of Omicron, its propensity to rapidly dominate small populations, and the ability of robust asymptomatic surveillance programs to offer early insights into the dynamics of pathogen arrival and spread.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Clin Infect Dis Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Clin Infect Dis Ano de publicação: 2023 Tipo de documento: Article